In situ hybridisation and S1 mapping show that the presence of infiltrating plasma cells is associated with poor prognosis in breast cancer.
AffiliationCancer Research Campaign Tumour Endocrinology Group, Medical Molecular Biology Unit, University College and Middlesex School of Medicine, London, UK.
MetadataShow full item record
AbstractIn order to identify potential markers of prognosis in breast cancer, representative cDNA libraries were constructed using RNA isolated from primary breast tumour tissue associated with good and poor prognosis. Cross-screening of these libraries repeatedly identified cloned mRNA species associated with the immune system, in particular B-cells, in libraries derived from tumours of poor prognosis. We have used one of these a kappa IV light chain cDNA probe, in two complementary studies to investigate the relationship between immunoglobin gene expression and prognosis. The results obtained using a combination of S1 mapping, RNA blotting and in situ hybridisation demonstrate that the presence of plasma cells, as defined by infiltrating cells which express high levels of immunoglobulin kappa-chain mRNA, is associated with a poor prognosis.
CitationIn situ hybridisation and S1 mapping show that the presence of infiltrating plasma cells is associated with poor prognosis in breast cancer. 1988, 58 (6):715-22 Br J Cancer
JournalBritish Journal of Cancer
- Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
- Authors: Yang DC, Wang F, Elliott RL, Head JF
- Issue date: 2001 Jan-Feb
- Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
- Authors: Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y
- Issue date: 2006 May
- Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
- Authors: Quintela-Fandino M, López JM, Hitt R, Gamarra S, Jimeno A, Ayala R, Hornedo J, Guzman C, Gilsanz F, Cortés-Funes H
- Issue date: 2006 Aug 1
- Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
- Authors: Ghadersohi A, Sood AK
- Issue date: 2001 Sep
- CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
- Authors: Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C
- Issue date: 2009